Dose-dependent improvements in outcome with adenoviral expression of interleukin-10 in a murine model of multisystem organ failure.
- Published in:
- Gene Therapy, 2006, v. 13, n. 3, p. 276, doi. 10.1038/sj.gt.3302600
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2006 AND VI 13 AND IP 3
Results: 11
1
2
Cancer Gene Therapy: The power of negative thinking.
- Published in:
- Gene Therapy, 2006, v. 13, n. 3, p. 191, doi. 10.1038/sj.gt.3302633
- By:
- Publication type:
- Article
3
RNAi Therapy: Antibodies guide the way.
- Published in:
- Gene Therapy, 2006, v. 13, n. 3, p. 194, doi. 10.1038/sj.gt.3302634
- By:
- Publication type:
- Article
4
The tumor suppressor activity induced by adenovirus-mediated BRCA1 overexpression is not restricted to breast cancers.
- Published in:
- Gene Therapy, 2006, v. 13, n. 3, p. 235, doi. 10.1038/sj.gt.3302637
- By:
- Publication type:
- Article
5
Intramuscular immunization with plasmid coexpressing tumour antigen and Flt-3L results in potent tumour regression.
- Published in:
- Gene Therapy, 2006, v. 13, n. 3, p. 245, doi. 10.1038/sj.gt.3302639
- By:
- Publication type:
- Article
6
Hypoxia- and radiation-activated Cre/loxP ‘molecular switch’ vectors for gene therapy of cancer.
- Published in:
- Gene Therapy, 2006, v. 13, n. 3, p. 206, doi. 10.1038/sj.gt.3302640
- By:
- Publication type:
- Article
7
Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1.
- Published in:
- Gene Therapy, 2006, v. 13, n. 3, p. 225, doi. 10.1038/sj.gt.3302641
- By:
- Publication type:
- Article
8
Differential cellular responses to exogenous DNA in mammalian cells and its effect on oligonucleotide-directed gene modification.
- Published in:
- Gene Therapy, 2006, v. 13, n. 3, p. 266, doi. 10.1038/sj.gt.3302643
- By:
- Publication type:
- Article
9
Liver-directed gene therapy of diabetic rats using an HVJ-E vector containing EBV plasmids expressing insulin and GLUT 2 transporter.
- Published in:
- Gene Therapy, 2006, v. 13, n. 3, p. 216, doi. 10.1038/sj.gt.3302644
- By:
- Publication type:
- Article
10
A combination of DNA vaccines targeting human papillomavirus type 16 E6 and E7 generates potent antitumor effects.
- Published in:
- Gene Therapy, 2006, v. 13, n. 3, p. 257, doi. 10.1038/sj.gt.3302646
- By:
- Publication type:
- Article
11
A replication competent lentivirus (RCL) assay for equine infectious anaemia virus (EIAV)-based lentiviral vectors.
- Published in:
- Gene Therapy, 2006, v. 13, n. 3, p. 196, doi. 10.1038/sj.gt.3302666
- By:
- Publication type:
- Article